Supira Medical Stock

supiramedical.comHealthcare / Medical DevicesFounded: 2012Funding to Date: $121.09MM

Supira Medical, founded in 2012, is a medical device company that manufactures percutaneous ventricular assist devices (pVADs) designed to give temporary mechanical support to a patient’s heart and allow them to go through required interventional procedures. The devices aim to support patients with coronary artery disease undergoing high-risk percutaneous coronary intervention as well as severe heart attack patients suffering from cardiogenic shock. Supira Medical is headquartered in Los Gatos, California.

Register To Buy and Sell Shares

For more details on financing and valuation for Supira Medical, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Supira Medical’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Supira Medical.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.

Supira Medical investors also invested in these private companies


Management Team

Nitin Salunke Ph.D
Chief Executive Officer & President
David Voris
Chief Financial Officer
Janine Robinson
Vice President, Research and Development
Adnan Merchant
Vice President, Systems Engineering
Nicole Haratani
Vice President, Clinical Affairs
Jon Tanaka
Vice President, Operations
Ken Perino
Vice President, Quality
Robert Edesess
Vice President, Intellectual Property
Debbie White
Senior Vice President, Human Resources & Administration

Board Members

Amr Salahieh
Bihua Chen
Cormorant Asset Management
Casey Gordon
The Capital Partnership
Mariam Maghribi Ph.D

Supira Medical’s stock FAQs


Can you buy Supira Medical’s stock?

Supira Medical is not publicly traded on NYSE or NASDAQ in the U.S. To buy Supira Medical’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Can you sell Supira Medical’s stock?

Yes, you can sell stock of a private company like Supira Medical. Forge can help you sell your Supira Medical stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.

What is Supira Medical’s stock price?

Supira Medical is a privately held company and therefore does not have a public stock price. However, you may access Supira Medical’s private market stock price with Forge Data.

What is Supira Medical’s stock ticker symbol?

Supira Medical does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Supira Medical Closes $40M In Series D Financing

Supira Medical, a Los Gatos, CA-based company advancing a percutaneous ventricular assist device (pVAD), raised $40M in Series D funding. The round was led by Cormorant Asset Management and The Capital Partnership (TCP), with participation from 415 CAPITAL, AMED Ventures, PA MedTech VC fund, Unorthodox Ventures and Shifamed angel investors. The company intends to use the funds to expand its currently enrolling OUS studies, plan for its U.S. studies, and prepare for U.S. pivotal study submission.
Updated on: Jul 16, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.